Dash Barry H purchased $26K of ELTP
Dash Barry H purchased 100,000 shares of ELITE PHARMACEUTICALS INC /NV/ (ELTP) at $0.26 on 2026-10-09.
How this was made
The 30-second read
Why it matters
The filing provides the first public disclosure of this purchase; size is modest.
Market read
Small insider purchase with limited trading relevance.
What to watch
Director's overall stake is large; incremental purchase may not reflect broader company outlook.
Background
SEC Form 4 filing discloses insider transactions for public companies.
Ticker impact
Director Dash Barry H purchased 100,000 shares of Elite Pharmaceuticals at $0.2598, costing $25,980.
slight upward pressure as market digests insider purchase
Purchase amount is low relative to total holdings; unlikely to move price materially.
Market effects
Minimal impact on pharma sector; insider activity is routine.
None
None
Counterpoint
The purchase could be a tactical move unrelated to fundamentals.
Key entities
- CompanyElite Pharmaceuticals Inc.
US-listed pharmaceutical company (ticker ELTP).
- IndividualDash Barry H
Director of Elite Pharmaceuticals.